Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Building a better nucleoside/nucleotide analogue backbone: pharmacokinetic and resistance considerations.

The AIDS reader - 1 Sept 2003

Zolopa Andrew R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Drug Administration Schedule
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Reverse Transcriptase

Share to Patient Compliance

Share to Patient Selection

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 14601554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Building a better nucleoside/nucleotide analogue backbone: pharmacokinetic and resistance considerations.PMID 14601554Read ↗

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesSemantic proximity Read ↗

Genetic risks of antiviral nucleoside analogues – a surveySemantic proximity Read ↗

A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymeraseSemantic proximity Read ↗

Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus InfectionsSemantic proximity Read ↗

Nucleoside Analogues as Antibacterial AgentsSemantic proximity Read ↗

Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptasesSemantic proximity Read ↗

Designing drugs against heterogeneous targets.Semantic proximity Read ↗

Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesisSemantic proximity Read ↗

Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitorsSemantic proximity Read ↗

Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2Semantic proximity Read ↗

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?Semantic proximity Read ↗

[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.